Page last updated: 2024-08-17

medroxyprogesterone acetate and Skin Neoplasms

medroxyprogesterone acetate has been researched along with Skin Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, ML; Chlebowski, RT; Keiser, E; Larson, JC; Spaunhurst, KM; Stefanick, ML; Tang, JY; Thomas, F; Wactawski-Wende, J; Zeitouni, NC	1
Fukushima, M; Ono, Y; Sawada, M	1
Ausilli-Cefaro, GP; Minotti, G; Saccheri, S; Trodella, L; Turriziani, A; Venturo, I	1
Besch-Williford, C; Day, JK; Hufford, MG; Lubahn, DB; MacDonald, RS; McMann, TR	1

Trials

1 trial(s) available for medroxyprogesterone acetate and Skin Neoplasms

Article	Year
Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials. Journal of the National Cancer Institute, 2011, Oct-05, Volume: 103, Issue:19 Topics: Aged; Confounding Factors, Epidemiologic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Melanoma; Menopause; Middle Aged; Odds Ratio; Proportional Hazards Models; Risk Assessment; Risk Factors; Skin Neoplasms; Women's Health	2011

Article

Year

Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.

Journal of the National Cancer Institute, 2011, Oct-05, Volume: 103, Issue:19

Topics: Aged; Confounding Factors, Epidemiologic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Melanoma; Menopause; Middle Aged; Odds Ratio; Proportional Hazards Models; Risk Assessment; Risk Factors; Skin Neoplasms; Women's Health

2011

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Skin Neoplasms

Article	Year
[A case of advanced recurrent breast cancer responding to treatment with weekly docetaxel combined with doxorubicin]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Humans; Lung Neoplasms; Lymphatic Metastasis; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Middle Aged; Paclitaxel; Skin Neoplasms; Taxoids	2003
Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report. American journal of clinical oncology, 1982, Volume: 5, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Skin Neoplasms; Tamoxifen	1982
Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ER alpha KO, mice. Nutrition and cancer, 2001, Volume: 39, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Caseins; Diet; Estradiol; Estrogen Receptor alpha; Female; Genistein; Insulin-Like Growth Factor I; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Ovary; Receptors, Estrogen; Skin Neoplasms; Uterus; Weight Gain	2001